Are we getting Covid-19 boosters wrong? Which venture capitalists are missing their marks? And what’s Anthony Fauci’s legacy?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins to explain the Covid-19 booster debate, the Biden Administration’s monkeypox response, and the long career of the soon-to-step-down Anthony Fauci. We also discuss the latest news in the life sciences, including a milestone for gene therapy, the tentative return of an IPO market, and the venture capital league table.
Biopharma in a post-pandemic world: Creating a resilient industry together
Learning through a global pandemic, biopharma is evolving to embrace innovations that could unlock the next wave of life-saving diagnostics, vaccines, and therapies. Cytiva’s Global Biopharma Resilience Index helps us take stock of the opportunities and challenges that lie ahead for the industry, according to biopharma executives and policy makers. Here’s what the industry told us.
No comments